Zhongyi Fan

1.4k total citations
28 papers, 1.1k citations indexed

About

Zhongyi Fan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhongyi Fan has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Zhongyi Fan's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (4 papers). Zhongyi Fan is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (4 papers). Zhongyi Fan collaborates with scholars based in China, United States and Taiwan. Zhongyi Fan's co-authors include Lei Kang, Xiaojie Xu, Qinong Ye, Xuelin Zhang, Quanbo Ji, Xiang Yan, Jiahong Liu, Xiaofei Zheng, Zhifeng Yan and Yameng Xu and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zhongyi Fan

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongyi Fan China 17 760 570 223 116 80 28 1.1k
Zhu China 11 848 1.1× 700 1.2× 145 0.7× 96 0.8× 82 1.0× 95 1.3k
Srinivas Chava United States 20 614 0.8× 400 0.7× 154 0.7× 251 2.2× 73 0.9× 41 1.2k
Yisheng Pan China 18 480 0.6× 270 0.5× 158 0.7× 123 1.1× 148 1.9× 54 968
Weihong Zhao China 19 692 0.9× 389 0.7× 214 1.0× 176 1.5× 85 1.1× 68 1.1k
Xiangyang Lin China 17 466 0.6× 256 0.4× 92 0.4× 107 0.9× 64 0.8× 38 915
Sumadi Lukman Anwar Indonesia 18 622 0.8× 457 0.8× 287 1.3× 92 0.8× 77 1.0× 77 1.0k
Wen-Shin Chang Taiwan 19 427 0.6× 456 0.8× 299 1.3× 39 0.3× 73 0.9× 72 989
Jue Wei China 17 487 0.6× 302 0.5× 112 0.5× 272 2.3× 81 1.0× 30 934
Xingbo Song China 18 460 0.6× 341 0.6× 63 0.3× 151 1.3× 52 0.7× 53 865
Xiaopeng Yu China 16 372 0.5× 190 0.3× 210 0.9× 256 2.2× 128 1.6× 40 940

Countries citing papers authored by Zhongyi Fan

Since Specialization
Citations

This map shows the geographic impact of Zhongyi Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongyi Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongyi Fan more than expected).

Fields of papers citing papers by Zhongyi Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongyi Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongyi Fan. The network helps show where Zhongyi Fan may publish in the future.

Co-authorship network of co-authors of Zhongyi Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongyi Fan. A scholar is included among the top collaborators of Zhongyi Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongyi Fan. Zhongyi Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Jingjing, Yin Chen, Ning Li, et al.. (2024). Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma. Chinese Journal of Cancer Research. 36(4). 351–367.
2.
Zou, Bo, Ning Li, Zhongyi Fan, et al.. (2024). Biomarkers for predicting efficacy of chimeric antigen receptor T cell therapy and their detection methods. SHILAP Revista de lepidopterología. 2(1). 14–26. 1 indexed citations
3.
Fan, Zhongyi, et al.. (2024). Measuring the Success of Global Sports Governance: A Deep Trust Network Model Approach. Journal of Psycholinguistic Research. 53(2). 17–17.
4.
Hu, Xiaomei & Zhongyi Fan. (2023). Games to Control Gaming Behavior: An Observation Based on Teenager Families. Deviant Behavior. 45(2). 267–286. 1 indexed citations
5.
Yang, Yang, et al.. (2023). Salmonella typhimurium targeting with monoclonal antibodies prevents infection in mice. PLoS neglected tropical diseases. 17(12). e0011579–e0011579. 3 indexed citations
6.
Fan, Zhongyi, Jingjing Duan, Lingxiong Wang, et al.. (2019). PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling. Cancer Letters. 450. 132–143. 83 indexed citations
7.
Fan, Zhongyi, Jing Yang, Dong Zhang, et al.. (2018). The risk variant rs884225 within EGFR impairs miR-103a-3p’s anti-tumourigenic function in non-small cell lung cancer. Oncogene. 38(13). 2291–2304. 20 indexed citations
8.
Ji, Quanbo, Xiaojie Xu, Yameng Xu, et al.. (2018). Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis. Molecular Therapy — Nucleic Acids. 11. 170–179. 26 indexed citations
9.
Duan, Jingjing, et al.. (2018). A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy. Journal for ImmunoTherapy of Cancer. 6(1). 100–100. 50 indexed citations
10.
Fan, Zhongyi, et al.. (2018). Preference of cancer patients and family members regarding delivery of bad news and differences in clinical practice among medical staff. Supportive Care in Cancer. 27(2). 583–589. 28 indexed citations
11.
Xu, Xiaojie, Shuai Jin, Yongfu Ma, et al.. (2017). miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression. Journal of Molecular Medicine. 95(8). 861–871. 55 indexed citations
12.
Ji, Quanbo, Xiaojie Xu, Yameng Xu, et al.. (2016). miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage. Journal of Molecular Medicine. 94(6). 681–694. 59 indexed citations
13.
Fan, Zhongyi, Xiaojie Xu, Xuelin Zhang, et al.. (2015). MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Oncotarget. 6(28). 25266–25280. 126 indexed citations
14.
Kang, Lei, Zhongyi Fan, Hongwei Sun, et al.. (2015). Improved synthesis and biological evaluation of Tc‐99m radiolabeled AMO for miRNA imaging in tumor xenografts. Journal of Labelled Compounds and Radiopharmaceuticals. 58(13-14). 461–468. 9 indexed citations
15.
Kang, Lei, et al.. (2015). Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. Tumor Biology. 36(8). 6295–6304. 88 indexed citations
16.
Fan, Zhongyi, Xiaojie Xu, Xiaomei Zhang, et al.. (2015). [FHL1 knockdown mediated by lentiviral shRNA promotes the growth of HeLa and HepG2 cells].. PubMed. 31(7). 879–83. 5 indexed citations
17.
Wang, Yu, Jie Fu, Mengmeng Jiang, et al.. (2014). MiR-410 Is Overexpressed in Liver and Colorectal Tumors and Enhances Tumor Cell Growth by Silencing FHL1 via a Direct/Indirect Mechanism. PLoS ONE. 9(10). e108708–e108708. 52 indexed citations
18.
Xu, Xiaojie, Zhongyi Fan, Lei Kang, et al.. (2013). Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. Journal of Clinical Investigation. 123(2). 630–45. 225 indexed citations
19.
Xu, Xiaojie, Cheng‐Ying Jiang, Shibin Wang, et al.. (2013). HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition. IUBMB Life. 65(10). 873–882. 26 indexed citations
20.
Han, Juqiang, Xiaojie Xu, Anheng Liu, et al.. (2013). The molecular mechanism and potential role of heat shock-induced p53 protein accumulation. Molecular and Cellular Biochemistry. 378(1-2). 161–169. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026